Clinical
|
DNMT3A (DNA methyltransferase 1) • JAK2 (Janus kinase 2) • SF3B1 (Splicing Factor 3b Subunit 1) • ASXL1 (ASXL Transcriptional Regulator 1) • TET2 (Tet Methylcytosine Dioxygenase 2) • B2M (Beta-2-microglobulin) • GDF15 (Growth differentiation factor 15) • IL10 (Interleukin 10) • TIMP1 (Tissue inhibitor of metalloproteinases 1) • IL18 (Interleukin 18) • TGFB1 (Transforming Growth Factor Beta 1) • VCAM1 (Vascular Cell Adhesion Molecule 1) • ERFE (Erythroferrone)
|
DNMT3A mutation • ASXL1 mutation • TET2 mutation • SF3B1 mutation • JAK2 V617F • JAK2 mutation
|
Jakafi (ruxolitinib) • Reblozyl (luspatercept-aamt)